Clinical Trial Update: Satisfaction in Patients Receiving the PegIntron Pen Plus Rebetol for Hepatitis C (Study P04244)(COMPLETED)

View source ↗

Summary

A completed clinical trial evaluating patient satisfaction with PegIntron Pen plus Rebetol in chronic hepatitis C patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron Pen (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Schering-Plough | Conditions: Hepatitis C, Chronic, Hepacivirus | Status: COMPLETED | Results posted: 2009-07-17